New Horizons in Antiretroviral Drug Delivery Systems for HIV Management

This review examines innovative approaches for HIV treatment, where various drug delivery systems have shown significant advantages, such as high drug encapsulation, improved solubility, and enhanced bioavailability both in vitro and in vivo. Strategies like cyclodextrins, solid dispersions, microneedles, and nanoparticles are explored to address challenges in drug solubility, bioavailability, and administration routes. Despite progress, obstacles like limited clinical trials and industrial scalability hinder the widespread adoption of these formulations, emphasizing the need for further research and collaboration to optimize and ensure accessibility of innovative HIV therapies, mainly in regions where access to HIV treatment is scarce and remains a challenge.

Authors

Institutions

Publication Details

Journal
Current Medicinal Chemistry
Published
2024-08-12
DOI
https://doi.org/10.2174/0109298673306606240802111136
Citations
1
Primary Topic
HIV/AIDS drug development and treatment
Type
article
Field-Weighted Citation Impact
0.39
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

New Horizons in Antiretroviral Drug Delivery Systems for HIV Management

José Lamartine Soares‐Sobrinho, Kayque Almeida dos Santos, Lívia Maria Coelho de Carvalho Moreira, Mônica Felts de La Roca Soares
1 citations
Current Medicinal Chemistry
HIV/AIDS drug development and treatment
0.39
article

New Horizons in Antiretroviral Drug Delivery Systems for HIV Management

José Lamartine Soares‐Sobrinho, Kayque Almeida dos Santos, Lívia Maria Coelho de Carvalho Moreira, Mônica Felts de La Roca Soares
article en
1 citations

Abstract

This review examines innovative approaches for HIV treatment, where various drug delivery systems have shown significant advantages, such as high drug encapsulation, improved solubility, and enhanced bioavailability both in vitro and in vivo. Strategies like cyclodextrins, solid dispersions, microneedles, and nanoparticles are explored to address challenges in drug solubility, bioavailability, and administration routes. Despite progress, obstacles like limited clinical trials and industrial scalability hinder the widespread adoption of these formulations, emphasizing the need for further research and collaboration to optimize and ensure accessibility of innovative HIV therapies, mainly in regions where access to HIV treatment is scarce and remains a challenge.

Current Medicinal ChemistryVol. 32(21)
Universidade Federal de Pernambuco (BR)
Good health and well-being
Openalex Percentile: Top 38%
HIV/AIDS drug development and treatment
0.39
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.